Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population.


CONTEXT Approximately 2.7 million US individuals are chronically infected with the hepatitis C virus (HCV). As public health campaigns are pursued, a growing number of treatment candidates are likely to have minimal evidence of liver damage. OBJECTIVE To examine the clinical benefits and cost-effectiveness of newer treatments for chronic hepatitis C… (More)


8 Figures and Tables